Comparison of Escherichia coli ST131 Pulsotypes, by Epidemiologic Traits, 1967–2009

Affordable Access

Publisher Website

Comparison of Escherichia coli ST131 Pulsotypes, by Epidemiologic Traits, 1967–2009

Authors
Publisher
Centers for Disease Control and Prevention
Volume
18
Issue
4
Identifiers
DOI: 10.3201/eid1804.111627
Keywords
  • Research

Abstract

Escherichia coli sequence type 131 (ST131), an emerging disseminated public health threat, causes multidrug-resistant extraintestinal infections. Among 579 diverse E. coli ST131 isolates from 1967–2009, we compared pulsotypes (>94% similar XbaI pulsed-field gel electrophoresis profiles) by collection year, geographic origin, source, and antimicrobial drug–resistance traits. Of 170 pulsotypes, 65 had >2 isolates and accounted for 85% of isolates. Although extensively dispersed geographically, pulsotypes were significantly source specific (e.g., had little commonality between humans vs. foods and food animals). The most prevalent pulsotypes were associated with recent isolation, humans, and antimicrobial drug resistance. Predominant pulsotype 968 was associated specifically with fluoroquinolone resistance but not with extended-spectrum β-lactamase production or blaCTX-M-15. Thus, several highly successful antimicrobial drug–resistant lineages within E. coli ST131 have recently emerged and diffused extensively among locales while maintaining a comparatively restricted host/source range. Identification of factors contributing to this behavior of ST131 could help protect public health.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Molecular epidemiological analysis of Escherichia...

on Antimicrobial Agents and Chemo... May 2012

Genotypic and phenotypic profiles of Escherichia c...

on Antimicrobial Agents and Chemo... December 2014

Molecular epidemiology and virulence of Escherichi...

on International Journal of Medic... November 2014

Bacteremia caused by extended-spectrum-β-lactamase...

on Antimicrobial Agents and Chemo... February 2012
More articles like this..